TY - JOUR T1 - Authors' response JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 525 LP - 525 DO - 10.1136/bjo.2009.166918 VL - 94 IS - 4 AU - Michael Georgopoulos AU - Kaija Polak AU - Franz Prager AU - Christian Prünte AU - Ursula Schmidt-Erfurth Y1 - 2010/04/01 UR - http://bjo.bmj.com/content/94/4/525.2.abstract N2 - We appreciate the interest of Muhammad Raja et al in our article and would like to thank them for their useful contribution. We read with interest their similar findings in one patient they have treated with bevacizumab (Avastin) who … ER -